硫唑嘌呤治疗的风险与益处。
Risks and benefits of azathioprine therapy.
作者信息
McGovern D P B, Jewell D P
机构信息
The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK.
出版信息
Gut. 2005 Aug;54(8):1055-9. doi: 10.1136/gut.2004.053231.
Abstract
The risk of lymphoma may be increased by about fourfold in patients with inflammatory bowel disease treated with thiopurines. The increased risk could be a result of the medications, the severity of the underlying disease, or a combination of the two.
摘要
接受硫嘌呤治疗的炎症性肠病患者患淋巴瘤的风险可能会增加约四倍。风险增加可能是药物、潜在疾病的严重程度或两者共同作用的结果。
相似文献
1
Risks and benefits of azathioprine therapy.硫唑嘌呤治疗的风险与益处。
Gut. 2005 Aug;54(8):1055-9. doi: 10.1136/gut.2004.053231.
2
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.炎症性肠病中的急性胰腺炎，特别提及硫唑嘌呤诱发的胰腺炎。
Aliment Pharmacol Ther. 2008 Sep 1;28(5):623-8. doi: 10.1111/j.1365-2036.2008.03746.x. Epub 2008 May 30.
3
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.接受硫唑嘌呤和6-巯基嘌呤治疗的炎症性肠病患者患淋巴瘤的风险增加。
Gut. 2005 Aug;54(8):1121-5. doi: 10.1136/gut.2004.049460.
4
Safety profile of IBD: lymphoma risks.IBD 的安全性概况：淋巴瘤风险。
Gastroenterol Clin North Am. 2009 Dec;38(4):669-89. doi: 10.1016/j.gtc.2009.07.004.
5
Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study.炎症性肠病患者使用硫唑嘌呤治疗后的癌症风险：一项基于英国人群的病例对照研究。
Am J Gastroenterol. 2010 Jul;105(7):1604-9. doi: 10.1038/ajg.2009.745. Epub 2010 Jan 26.
6
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的硫嘌呤甲基转移酶基因多态性
Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.
7
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.硫嘌呤甲基转移酶活性联合6-硫鸟嘌呤代谢物水平可预测炎症性肠病患者对硫嘌呤类药物的临床反应。
Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4.
8
Use of azathioprine and the risk of cancer in inflammatory bowel disease.巯嘌呤在炎症性肠病中的应用与癌症风险。
Am J Epidemiol. 2013 Jun 1;177(11):1296-305. doi: 10.1093/aje/kws375. Epub 2013 Mar 20.
9
[Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].[慢性炎症性肠病免疫抑制治疗的获益与风险]
Dtsch Med Wochenschr. 2008 Sep;133(38):1917-21. doi: 10.1055/s-0028-1085577. Epub 2008 Sep 10.
10
Risk of lymphoma: inflammatory bowel disease and immunomodulators.淋巴瘤风险：炎症性肠病与免疫调节剂
Gut. 2006 Apr;55(4):580-1.
引用本文的文献
1
A Case Report of Follicular Lymphoma in a Crohn's Disease Patient Treated With Azathioprine.1例接受硫唑嘌呤治疗的克罗恩病患者并发滤泡性淋巴瘤的病例报告
Cureus. 2023 Dec 20;15(12):e50839. doi: 10.7759/cureus.50839. eCollection 2023 Dec.
2
Diffuse large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis: a case report.一名接受硫唑嘌呤治疗溃疡性结肠炎的患者发生弥漫性大B细胞淋巴瘤：病例报告
Ann Med Surg (Lond). 2023 Apr 7;85(5):2059-2063. doi: 10.1097/MS9.0000000000000562. eCollection 2023 May.
3
Common Gastrointestinal Medications Implicated in Drug-Induced Liver Injury.与药物性肝损伤相关的常见胃肠道药物。
Clin Liver Dis (Hoboken). 2021 Oct 27;18(4):184-188. doi: 10.1002/cld.1110. eCollection 2021 Oct.
4
Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT.硫唑嘌呤类药物治疗溃疡性结肠炎：TPMT 中一种新的有害突变的鉴定。
Genes (Basel). 2020 Oct 16;11(10):1212. doi: 10.3390/genes11101212.
5
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.硫唑嘌呤在炎症性肠病中的治疗：临床药理学及药物基因组学指导给药的意义
Clin Pharmacokinet. 2007;46(3):187-208. doi: 10.2165/00003088-200746030-00001.
本文引用的文献
1
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.接受硫唑嘌呤和6-巯基嘌呤治疗的炎症性肠病患者患淋巴瘤的风险增加。
Gut. 2005 Aug;54(8):1121-5. doi: 10.1136/gut.2004.049460.
2
Smoking and non-Hodgkin's lymphoma: a case-control study in the Rhône-Alpes region of France.吸烟与非霍奇金淋巴瘤：法国罗纳-阿尔卑斯地区的一项病例对照研究。
Cancer Causes Control. 2003 May;14(4):381-9. doi: 10.1023/a:1023978730962.
3
Cancer risk in patients with inflammatory bowel disease: a population-based study.炎症性肠病患者的癌症风险：一项基于人群的研究。
Cancer. 2001 Feb 15;91(4):854-62. doi: 10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z.
4
Risk of lymphoma in inflammatory bowel disease.炎症性肠病患者患淋巴瘤的风险。
Am J Gastroenterol. 2000 Sep;95(9):2308-12. doi: 10.1111/j.1572-0241.2000.02316.x.
5
Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.硫唑嘌呤用于维持克罗恩病缓解：益处大于淋巴瘤风险。
Gastroenterology. 2000 Jun;118(6):1018-24. doi: 10.1016/s0016-5085(00)70353-2.
6
Effect of cigarette smoking on recurrence of Crohn's disease.吸烟对克罗恩病复发的影响。
Gastroenterology. 1990 May;98(5 Pt 1):1123-8. doi: 10.1016/0016-5085(90)90324-t.
Zotero 插件